Enzymes Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Enzymes's estimated annual revenue is currently $6.2M per year.(i)
  • Enzymes's estimated revenue per employee is $155,000

Employee Data

  • Enzymes has 40 Employees.(i)
  • Enzymes grew their employee count by -7% last year.

Enzymes's People

NameTitleEmail/Phone
1
Sr. Scientist IReveal Email/Phone
2
ProcurementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Enzymes?

Verenium Corporation, now part of BASF, is an industrial biotechnology company and global leader in developing high-performance enzymes. Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets. Our enzymes are developed by tapping into the vast genetic reservoir of bacteria and fungi — nature's most abundant resource — to create high-performance industrial enzyme solutions. Our unique R&D capabilities allow us to harness the energy of nature to develop and sell our enzymes to a global market. More than ever, a growing number of organizations are focused on developing ‘greener' processes and products. Corporate social responsibility and fierce global competition encourage industry leaders to seek greater efficiency and higher performance. Industries are looking to improve process economics in an environmentally sustainable way. Verenium has assembled all the capabilities and expertise needed to create eco-sensitive, enzymatic bioprocesses that replace inefficient, often harsh chemical processes. Enzymes are not just the future of industry; they are transforming industries and responding to market demands today. The company is headquartered in San Diego, California. Read more at www.verenium.com.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$6.2M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Enzymes News

2022-04-20 - Scientists Find an Enzyme That May Stop Brain Activity Getting Out of Control

The two proteins – Rab3-interacting molecule 1 (RIM1) and an enzyme called serine arginine protein kinase 2 (SRPK2) – work together to...

2022-04-19 - Photosynthesis May Be Improved by the Use of Ancient ...

The team found that ancient Rubisco enzymes predicted from modern-day Solanaceae plants showed real promise for being more efficient. “For the...

2022-04-17 - Israeli startup uses AI to design novel enzymes, cutting cost of ...

Enzymes are massive protein molecules and as such have many different ways they can be assembled. If fact, the quantifier 'many' doesn't quite...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.1M40-7%N/A
#2
$4.6M40-13%N/A
#3
$4.6M400%N/A
#4
$4.6M40N/AN/A
#5
$9.9M400%$10.8M